DHR Stock Quote Price and Forecast | CNN

DHR

Danaher Corporation

Key terms

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Apr 08 9:46pm ET RBC Capital Reaffirms Their Buy Rating on Danaher (DHR) by TipRanks Apr 01 4:22pm ET Danaher files automatic mixed securities shelf by TipRanks Mar 27 3:36pm ET Danaher put volume heavy and directionally bearish by TipRanks Mar 25 2:05pm ET Ingersoll-Rand’s Dover deal not a threat to bioprocessing space, says KeyBanc by TipRanks Mar 15 9:39am ET China stimulus positive for GE HealthCare, tool companies, says Evercore ISI by TipRanks Feb 14 5:12pm ET Third Point buys McKesson, exits T-Mobile in Q4 by TipRanks Jan 31 9:46am ET Danaher price target raised to $282 from $254 at RBC Capital by TipRanks Jan 31 9:37am ET Danaher price target raised to $270 from $250 at Deutsche Bank by TipRanks Jan 31 9:17am ET Optimistic Outlook for Danaher: Buy Rating Affirmed Amid Recovery and Improved Target Price by TipRanks Jan 31 9:17am ET Danaher price target raised to $280 from $255 at Citi by TipRanks Jan 31 8:31am ET Danaher price target raised to $255 from $250 at Leerink by TipRanks Jan 31 8:20am ET Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Cencora (COR) by TipRanks Jan 31 7:33am ET Danaher price target raised to $280 from $265 at TD Cowen by TipRanks Jan 31 7:09am ET Danaher price target raised to $300 from $270 at JPMorgan by TipRanks Jan 31 7:05am ET Danaher price target raised to $259 from $252 at Baird by TipRanks Jan 31 5:31am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kura Oncology (KURA), HCA Healthcare (HCA) and Danaher (DHR) by TipRanks Jan 31 3:30am ET Wall Street Analysts Are Neutral on Top Healthcare Picks by TipRanks Jan 30 8:55pm ET Buy Rating Affirmed for Danaher with Increased Price Target Amid Strong Growth and Conservative Guidance by TipRanks Jan 30 6:10am ET Danaher sees FY24 revenue down low-single digits, consensus $24.05B by TipRanks Jan 30 6:07am ET Danaher sees Q1 revenue down high-single digits, consensus $5.73B by TipRanks Jan 30 6:04am ET Danaher reports Q4 adjusted EPS $2.09, consensus $1.89 by TipRanks Jan 29 8:25pm ET Notable companies reporting before tomorrow’s open by TipRanks Jan 29 12:50pm ET Notable companies reporting before tomorrow’s open by TipRanks Jan 26 8:45pm ET RBC Capital Keeps Their Buy Rating on Danaher (DHR) by TipRanks Jan 26 9:55am ET Early notable gainers among liquid option names on January 26th by TipRanks Jan 24 3:45pm ET Danaher call volume above normal and directionally bullish by TipRanks Jan 24 10:04am ET Netflix upgraded, Tesla initiated: Wall Street’s top analyst calls by TipRanks Jan 24 7:16am ET Danaher downgraded to Equal Weight on valuation at Barclays by TipRanks Jan 24 6:10am ET Danaher downgraded to Equal Weight from Overweight at Barclays by TipRanks Jan 11 1:30am ET Buy Rating Affirmed: Danaher’s Strong Q4 Performance and Market Leadership in Bioprocessing by TipRanks Jan 09 9:25am ET Danaher (NYSE:DHR) Drops on Dismal Q4 Outlook by TipRanks

Apr 13 5:09am ET Billionaire Dan Loeb Just Bought 1 Shocking Stock by Motley Fool

No recent press releases are available for DHR

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.

Joe Raedle/Getty Images

Trump stock tanks after announcing massive share sale

1040 US Individual Income Tax Return Form

Nora Carol Photography/Moment RF/Getty Images

Three ways investors can minimize their tax payments

People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.

Spencer Platt/Getty Images

Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel

JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.

Win McNamee/Getty Images

Jamie Dimon says chance of a bad economy is ‘higher than other people think’